The GenBank accession number for the sequence reported in this paper is AF188621.
Azole resistance in Candida albicans can be mediated by several resistance mechanisms. Among these, alterations of the azole target enzyme and the overexpression of multidrug efflux transporter genes are the most frequent. To identify additional putative azole resistance genes in C. albicans, a genomic library from this organism was screened for complementation of fluconazole hypersusceptibility in Saccharomyces cerevisiae YKKB-13 lacking the ABC (ATP-binding cassette) transporter gene PDR5. Among the C. albicans genes obtained, a new gene was isolated and named FLU1 (fluconazole resistance). The deduced amino acid sequence of FLU1 showed similarity to CaMDR1 (formerly BENr), a member of the major facilitator superfamily of multidrug efflux transporters. The expression of FLU1 in YKKB-13 mediated not only resistance to fluconazole but also to cycloheximide among the different drugs tested. The disruption of FLU1 in C. albicans had only a slight effect on fluconazole susceptibility; however, it resulted in hypersusceptibility to mycophenolic acid, thus suggesting that this compound could be a substrate for the protein encoded by FLU1. Disruption of FLU1 in a background of C. albicans mutants with deletions in several multidrug efflux transporter genes, including CDR1, CDR2 and CaMDR1, resulted in enhanced susceptibility to several azole derivatives. FLU1 expression did not vary significantly between several pairs of azole-susceptible and azole-resistant C. albicans clinical isolates. Therefore, FLU1 seems not to be required for the development of azole resistance in clinical isolates.
Alarco, A. M., Balan, I., Talibi, D., Mainville, N. & Raymond, M. (1997; ).AP1-mediated multidrug resistance in Saccharomyces cerevisiae requires FLR1 encoding a transporter of the major facilitator superfamily. J Biol Chem 272, 19304-19313.[CrossRef]
Amakasu, H., Suzuki, Y., Nishizawa, M. & Fukasawa, T. (1993; ). Isolation and characterization of SGE1: a yeast gene that partially suppresses the gal11 mutation in multiple copies. Genetics 134, 675-683.
Ben-Yaacov, R., Knoller, S., Caldwell, G. A., Becker, J. M. & Koltin, Y. (1994; ).Candida albicans gene encoding resistance to benomyl and methotrexate is a multidrug resistance gene. Antimicrob Agents Chemother 38, 648-652.[CrossRef]
Bissinger, P. H. & Kuchler, K. (1994; ). Molecular cloning and expression of the Saccharomyces cerevisiae STS1 gene product. A yeast ABC transporter conferring mycotoxin resistance. J Biol Chem 269, 4180-4186.
Boerlin, P., Boerlin-Petzold, F., Goudet, J., Durussel, C., Pagani, J. L., Chave, J. P. & Bille, J. (1996; ). Typing Candida albicans oral isolates from human immunodeficiency virus-infected patients by multilocus enzyme electrophoresis and DNA fingerprinting. J Clin Microbiol 34, 1235-1248.
Chen, W. & Struhl, K. (1988; ). Saturation mutagenesis of a yeast his3 ‘TATA element’: genetic evidence for a specific TATA-binding protein. Proc Natl Acad Sci USA 85, 2691-2695.[CrossRef]
Chibana, H., Magee, B. B., Grindle, S., Ran, Y., Scherer, S. & Magee, P. T. (1998; ). A physical map of chromosome 7 of Candida albicans. Genetics 149, 1739-1752.
Decottignies, A., Lambert, L., Catty, P., Degand, H., Epping, E. A., Moye-Rowley, W. S., Balzi, E. & Goffeau, A. (1995; ). Identification and characterization of SNQ2, a new multidrug ATP binding cassette transporter of the yeast plasma membrane. J Biol Chem 270, 18150-18157.[CrossRef]
Ehrenhofer-Murray, A. E., Wurgler, F. E. & Sengstag, C. (1994; ). The Saccharomyces cerevisiae SGE1 gene product: a novel drug-resistance protein within the major facilitator superfamily. Mol Gen Genet 244, 287-294.
Ellenberger, T. E., Brandl, C. J., Struhl, K. & Harrison, S. C. (1992; ). The GCN4 basic region leucine zipper binds DNA as a dimer of uninterrupted alpha helices: crystal structure of the protein–DNA complex. Cell 71, 1223-1237.[CrossRef]
Feinberg, A. P. & Vogelstein, B. (1984; ). A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 137, 266-267.[CrossRef]
Fling, M. E., Kopf, J., Tamarkin, A., Gorman, J. A., Smith, H. A. & Koltin, Y. (1991; ). Analysis of a Candida albicans gene that encodes a novel mechanism for resistance to benomyl and methotrexate. Mol Gen Genet 227, 318-329.
Goffeau, A., Park, J., Paulsen, I. T., Jonniaux, J. L., Dinh, T., Mordant, P. & Saier, M. H.Jr (1997; ). Multidrug-resistant transport proteins in yeast: complete inventory and phylogenetic characterization of yeast open reading frames with the major facilitator superfamily. Yeast 13, 43-54.[CrossRef]
Goldway, M., Teff, D., Schmidt, R., Oppenheim, A. B. & Koltin, Y. (1995; ). Multidrug resistance in Candida albicans: disruption of the BENr gene. Antimicrob Agents Chemother 39, 422-426.[CrossRef]
Gompel-Klein, P. & Brendel, M. (1990; ). Allelism of SNQ1 and ATR1, genes of the yeast Saccharomyces cerevisiae required for controlling sensitivity to 4-nitroquinoline-N-oxide and aminotriazole. Curr Genet 18, 93-96.[CrossRef]
Graham, T. R., Scott, P. A. & Emr, S. D. (1993; ). Brefeldin A reversibly blocks early but not late protein transport steps in the yeast secretory pathway. EMBO J 12, 869-877.
Hanahan, D. (1985; ). Techniques for transformation of E. coli. In DNA Cloning. A Practical Approach, pp. 109-135. Edited by D. M. Glover. Oxford: IRL Press.
Hube, B., Monod, M., Schofield, D. A., Brown, A. J. & Gow, N. A. (1994; ). Expression of seven members of the gene family encoding secretory aspartyl proteinases in Candida albicans. Mol Microbiol 14, 87-99.[CrossRef]
Jia, Z. P., McCullough, N., Wong, L. & Young, P. G. (1993; ). The amiloride resistance gene, car1, of Schizosaccharomyces pombe. Mol Gen Genet 241, 298-304.
Kanazawa, S., Driscoll, M. & Struhl, K. (1988; ).ATR1, a Saccharomyces cerevisiae gene encoding a transmembrane protein required for aminotriazole resistance. Mol Cell Biol 8, 664-673.
Kim, J. & Struhl, K. (1995; ). Determinants of half-site spacing preferences that distinguish AP-1 and ATF/CREB bZIP domains. Nucleic Acids Res 23, 2531-2537.[CrossRef]
Launhardt, H., Hinnen, A. & Munder, T. (1998; ). Drug-induced phenotypes provide a tool for the functional analysis of yeast genes. Yeast 14, 935-942.[CrossRef]
Morisaki, N., Funabashi, H., Shimazawa, R., Furukawa, J., Kawaguchi, A., Okuda, S. & Iwasaki, S. (1993; ). Effect of side-chain structure on inhibition of yeast fatty-acid synthase by cerulenin analogues. Eur J Biochem 211, 111-115.[CrossRef]
Mutoh, E., Mochizuki, M., Ohta, A. & Takagi, M. (1995; ). Inducible expression of a gene encoding an L41 ribosomal protein responsible for the cycloheximide-resistant phenotype in the yeast Candida maltosa. J Bacteriol 177, 5383-5386.
Nelissen, B., Mordant, P., Jonniaux, J. L., De Wachter, R. & Goffeau, A. (1995; ). Phylogenetic classification of the major superfamily of membrane transport facilitators, as deduced from yeast genome sequencing. FEBS Lett 377, 232-236.[CrossRef]
Odds, F. C., Schmid, J. & Soll, D. R. (1990; ). Epidemiology of Candida infections in AIDS. In Mycoses in AIDS Patients, pp. 67-74. Edited by N. Y. P. Press. New York: Plenum.
Odds, F. C., Dams, G., Just, G. & Lewi, P. (1996; ). Susceptibilities of Candida spp. to antifungal agents visualized by two-dimensional scatterplots of relative growth. Antimicrob Agents Chemother 40, 588-594.
Oliphant, A. R., Brandl, C. J. & Struhl, K. (1989; ). Defining the sequence specificity of DNA-binding proteins by selecting binding sites from random-sequence oligonucleotides: analysis of yeast GCN4 protein. Mol Cell Biol 9, 2944-2949.
Oskouian, B. & Saba, J. D. (1999; ).YAP1 confers resistance to the fatty acid synthase inhibitor cerulenin through the transporter Flr1p in Saccharomyces cerevisiae. Mol Gen Genet 261, 346-353.[CrossRef]
Prasad, R., De Wergifosse, P., Goffeau, A. & Balzi, E. (1995; ). Molecular cloning and characterization of a novel gene of Candida albicans, CDR1, conferring multiple resistance to drugs and antifungals. Curr Genet 27, 320-329.[CrossRef]
Rex, J. H., Pfaller, M. A., Barry, A. L., Nelson, P. W. & Webb, C. D. (1995; ). Antifungal susceptibility testing of isolates from a randomized, multicenter trial of fluconazole versus amphotericin B as treatment of nonneutropenic patients with candidemia. NIAID Mycoses Study Group and the Candidemia Study Group. Antimicrob Agents Chemother 39, 40-44.[CrossRef]
Sanglard, D., Kuchler, K., Ischer, F., Pagani, J. L., Monod, M. & Bille, J. (1995; ). Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters. Antimicrob Agents Chemother 39, 2378-2386.[CrossRef]
Sanglard, D., Ischer, F., Monod, M. & Bille, J. (1996; ). Susceptibilities of Candida albicans multidrug transporter mutants to various antifungal agents and other metabolic inhibitors. Antimicrob Agents Chemother 40, 2300-2305.
Sanglard, D., Ischer, F., Monod, M. & Bille, J. (1997; ). Cloning of Candida albicans genes conferring resistance to azole antifungal agents: characterization of CDR2, a new multidrug ABC transporter gene. Microbiology 143, 405-416.[CrossRef]
Sanglard, D., Ischer, F., Koymans, L. & Bille, J. (1998; ). Amino acid substitutions in the cytochrome P-450 lanosterol 14alpha-demethylase (CYP51A1) from azole-resistant Candida albicans clinical isolates contribute to resistance to azole antifungal agents. Antimicrob Agents Chemother 42, 241-253.[CrossRef]
Sanglard, D., Ischer, F., Calabrese, D., Majcherczyk, P. A. & Bille, J. (1999; ). The ATP Binding Cassette (ABC)-transporter gene CgCDR1 from Candida glabrata is involved in the resistance of clinical isolates to azole antifungal agents. Antimicrob Agents Chemother 43, 2753-2765.
Struhl, K., Chen, W., Hill, D. E., Hope, I. A. & Oettinger, M. A. (1985; ). Constitutive and coordinately regulated transcription of yeast genes: promoter elements, positive and negative regulatory sites, and DNA binding proteins. Cold Spring Harbor Symp Quant Biol 50, 489-503.[CrossRef]
Troillet, N., Durussel, C., Bille, J., Glauser, M. P. & Chave, J. P. (1993; ). Correlation between in vitro susceptibility of Candida albicans and fluconazole-resistant oropharyngeal candidiasis in HIV-infected patients. Eur J Clin Microbiol Infect Dis 12, 911-915.[CrossRef]
Vanden Bossche, H., Warnock, D. W., Dupont, B. & 7 other authors (1994; b). Mechanisms and clinical impact of antifungal drug resistance. J Med Vet Mycol 32, 189–202.